Apoptosis and the response to anticancer therapy

被引:82
|
作者
Mow, BMF
Blajeski, AL
Chandra, J
Kaufmann, SH
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Oncol Res, Rochester, MN 55905 USA
关键词
D O I
10.1097/00001622-200111000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis is a distinctive form of cell death that reflects cleavage of a subset of intracellular polypeptides by proteases known as caspases. Two major intracellular caspase cascades, one activated predominately by death receptor ligands and the other triggered by various cellular stresses, including DNA damage and microtubule disruption, have been delineated. Activation of these protease cascades is tightly regulated by a number of polypeptides, including Bcl-2 family members, inhibitor of apoptosis proteins, and several protein kinases. The demonstration that many antineoplastic agents induce apoptosis in susceptible cells raises the possibility that factors affecting caspase activation and activity might be important determinants of anticancer drug sensitivity. Here, we review recent studies describing the regulation of apoptotic pathways and identify potential implications of these findings for resistance to antineoplastic agents. Curr Opin Oncol 2001, 13:453-462 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:453 / 462
页数:10
相关论文
共 50 条
  • [31] Apoptosis pathways and anticancer treatment
    Debatin, KM
    2ND INTERNATIONAL CONGRESS ON GASTROENTEROLOGICAL CARCINOGENESIS, 1999, : 117 - 123
  • [32] Piezoelectric enhanced sulfur doped graphdiyne nanozymes for synergistic ferroptosis–apoptosis anticancer therapy
    Jianxin Wang
    Yinzhu Chu
    Zhiyu Zhao
    Cong Zhang
    Qi Chen
    Haitao Ran
    Yang Cao
    Changjun Wu
    Journal of Nanobiotechnology, 21 (1)
  • [33] Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy
    Bao, Weier
    Liu, Xianwu
    Lv, Yanlin
    Lu, Gui-Hong
    Li, Feng
    Zhang, Fan
    Liu, Bin
    Li, Dan
    Wei, Wei
    Li, Yuan
    ACS NANO, 2019, 13 (01) : 260 - 273
  • [34] JNK, essential for anticancer therapy-induced apoptosis, promotes breast cancer progression
    Wang, J.
    Kuiatse, I
    Casa, A. J.
    Lee, A., V
    Cui, X.
    CANCER RESEARCH, 2009, 69 (02) : 323S - 323S
  • [35] ANTICANCER THERAPY
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1952, 150 (10): : 1017 - 1017
  • [36] Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents
    Yadav, N.
    Kumar, S.
    Marlowe, T.
    Chaudhary, A. K.
    Kumar, R.
    Wang, J.
    O'Malley, J.
    Boland, P. M.
    Jayanthi, S.
    Kumar, T. K. S.
    Yadava, N.
    Chandra, D.
    CELL DEATH & DISEASE, 2015, 6 : e1969 - e1969
  • [37] Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents
    Kumar, Sandeep
    Yadav, Neelu
    Marlowe, Tim
    Chaudhary, Ajay
    Wang, Jianmin
    O'Malley, Jordan
    Boland, Patrick
    Jayanthi, Srinivas
    Kumar, Thallapuranam Krishnaswamy Suresh
    Yadava, Nagendra
    Chandra, Dhyan
    CANCER RESEARCH, 2015, 75
  • [38] Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction
    Pinto, Barbara
    Silva, Joao P. N.
    Silva, Patricia M. A.
    Barbosa, Daniel Jose
    Sarmento, Bruno
    Tavares, Juliana Carvalho
    Bousbaa, Hassan
    PHARMACEUTICS, 2024, 16 (01)
  • [39] Oxidative phosphorylation-dependent regulation of cancer cell apoptosis in response to anticancer agents
    N Yadav
    S Kumar
    T Marlowe
    A K Chaudhary
    R Kumar
    J Wang
    J O'Malley
    P M Boland
    S Jayanthi
    T K S Kumar
    N Yadava
    D Chandra
    Cell Death & Disease, 2015, 6 : e1969 - e1969
  • [40] IMPROVING THE RESPONSE TIME IN THE TREATMENT OF ANTICANCER THERAPY INDUCED HYPERSENSITIVITY REACTIONS
    Ciafre, Lisa
    Reiser, Patricia
    ONCOLOGY NURSING FORUM, 2019, 46 (02)